The European cell sheet-based gene approach market is experiencing significant growth. This industry is driven by an increasing requirement for innovative therapeutic solutions to address a broad range of genetic diseases. Successful clinical trials and regulatory authorizations are fueling market advancement. A key factor contributing to this phen… Read More